Vistin Pharma ASA (0RAM) Stock Statistics & Valuation Metrics

Vistin Pharma ASA has a market cap or net worth of kr900.20M. The enterprise value is kr1.15B.

Vistin Pharma ASA has 44,344,593 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vistin Pharma ASA’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Vistin Pharma ASA is 12.1. Vistin Pharma ASA’s PEG ratio is ―.

In the last 12 months, Vistin Pharma ASA had revenue of ― and earned 24.87M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Vistin Pharma ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Vistin Pharma ASA upcoming earnings date is Aug 20, 2026, TBA (Confirmed).

Vistin Pharma ASA as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Vistin Pharma ASA has paid ― in taxes.

Vistin Pharma ASA EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Vistin Pharma ASA has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Vistin Pharma ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―